Logo image of EMBK

Embark Technology Inc (EMBK) Stock Fundamental Analysis

NASDAQ:EMBK - US29079J2024 - Common Stock

2.88 USD
+0.01 (+0.35%)
Last: 8/1/2023, 8:00:02 PM
2.87 USD
-0.01 (-0.35%)
After Hours: 8/1/2023, 8:00:02 PM
Fundamental Rating

1

Overall EMBK gets a fundamental rating of 1 out of 10. We evaluated EMBK against 282 industry peers in the Software industry. The financial health of EMBK is average, but there are quite some concerns on its profitability. EMBK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EMBK had negative earnings in the past year.
In the past year EMBK has reported a negative cash flow from operations.
EMBK Yearly Net Income VS EBIT VS OCF VS FCFEMBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -50M -100M -150M

1.2 Ratios

The profitability ratios for EMBK are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMBK Yearly ROA, ROE, ROICEMBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -10 -20 -30 -40 -50

1.3 Margins

EMBK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMBK Yearly Profit, Operating, Gross MarginsEMBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for EMBK has been increased compared to 1 year ago.
EMBK has a worse debt/assets ratio than last year.
EMBK Yearly Shares OutstandingEMBK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 20M 40M 60M 80M 100M
EMBK Yearly Total Debt VS Total AssetsEMBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

EMBK has an Altman-Z score of -3.84. This is a bad value and indicates that EMBK is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.84, EMBK is doing worse than 85.71% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that EMBK is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, EMBK is in line with its industry, outperforming 58.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -3.84
ROIC/WACCN/A
WACCN/A
EMBK Yearly LT Debt VS Equity VS FCFEMBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 100M -100M 200M

2.3 Liquidity

EMBK has a Current Ratio of 11.38. This indicates that EMBK is financially healthy and has no problem in meeting its short term obligations.
EMBK has a Current ratio of 11.38. This is amongst the best in the industry. EMBK outperforms 96.43% of its industry peers.
EMBK has a Quick Ratio of 11.38. This indicates that EMBK is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EMBK (11.38) is better than 96.43% of its industry peers.
Industry RankSector Rank
Current Ratio 11.38
Quick Ratio 11.38
EMBK Yearly Current Assets VS Current LiabilitesEMBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 50M 100M 150M 200M 250M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.60% over the past year.
EPS 1Y (TTM)12.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-227.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, EMBK will show a very negative growth in Earnings Per Share. The EPS will decrease by -27.35% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-69.54%
EPS Next 2Y-27.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMBK Yearly Revenue VS EstimatesEMBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
EMBK Yearly EPS VS EstimatesEMBK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EMBK. In the last year negative earnings were reported.
Also next year EMBK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMBK Price Earnings VS Forward Price EarningsEMBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMBK Per share dataEMBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 -6

4.3 Compensation for Growth

EMBK's earnings are expected to decrease with -27.35% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.35%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EMBK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Embark Technology Inc

NASDAQ:EMBK (8/1/2023, 8:00:02 PM)

After market: 2.87 -0.01 (-0.35%)

2.88

+0.01 (+0.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-10 2023-08-10
Earnings (Next)11-06 2023-11-06
Inst Owners1.62%
Inst Owner Change0%
Ins Owners2.19%
Ins Owner Change0%
Market Cap70.20M
Analysts43.33
Price Target3.06 (6.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)18.37%
Min EPS beat(2)18.37%
Max EPS beat(2)18.37%
EPS beat(4)3
Avg EPS beat(4)30.66%
Min EPS beat(4)5.24%
Max EPS beat(4)68.37%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 0.56
EV/EBITDA N/A
EPS(TTM)-4.44
EYN/A
EPS(NY)-7.2
Fwd EYN/A
FCF(TTM)-4.9
FCFYN/A
OCF(TTM)-4.49
OCFYN/A
SpS0
BVpS5.16
TBVpS5.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 368%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.38
Quick Ratio 11.38
Altman-Z -3.84
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)349.02%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-227.4%
EPS Next Y-69.54%
EPS Next 2Y-27.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.75%
EBIT Next 3Y-10.05%
EBIT Next 5Y-11.83%
FCF growth 1Y-57.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.07%
OCF growth 3YN/A
OCF growth 5YN/A